Transcriptomic Profiling of Peripheral B Cells in Antibody Positive Sjogren’s Patients Reveals Interferon Signature
Genes · 2024
DOI: 10.3390/genes15050628 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Mehrnaz Maleki-Fischbach und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, National Jewish Health, Denver, CO 80206, USA. Hauptthemen laut MEDLINE: Sjogren's Syndrome, B-Lymphocytes, Transcriptome, Gene Expression Profiling. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: clinical academic development program award, National Jewish Health microgrant.
Abstract (Originalsprache)
Background
Sjögren’s disease (SjD) is a common systemic autoimmune disease that affects mainly women. Key pathologic features include the infiltration of exocrine glands by lymphocytes and the activation of B lymphocytes with the production of autoantibodies. We aimed to analyze the transcriptome of circulating B cells from patients with SJD and healthy controls to decipher the B-cell-specific contribution to SJD.
Methods
RNA from peripheral blood B cells of five untreated female patients with SjD and positive ANA, positive anti-SSA (both Ro-52 and Ro-60), positive anti-SSB and positive rheumatoid-factor, and five healthy controls was subjected to whole-transcriptome sequencing. A false discovery rate of < 0.1 was applied to define differentially expressed genes (DEG).
Results
RNA-sequencing identified 56 up and 23 down DEG. Hierarchal clustering showed a clear separation between the two groups. Ingenuity pathway analysis revealed that these genes may play a role in interferon signaling, chronic mycobacterial infection, and transformation to myeloproliferative disorders.
Conclusions
We found upregulated expression of type-I and type-II interferon (IFN)-induced genes, as well as genes that may contribute to other concomitant conditions, including infections and a higher risk of myeloproliferative disorders. This adds insight into the autoimmune process and suggests potential targets for future functional and prognostic studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, National Jewish Health, Denver, CO 80206, USA.
- Center for Genes, Environment, and Health, National Jewish Health, Denver, CO 80206, USA.
- Division of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, Denver, CO 80206, USA.
ORCID-Profile: Evans R Fernández Pérez
Förderung
- clinical academic development program award
- National Jewish Health microgrant
Zitieren
APA
Maleki-Fischbach, M., Anderson, K., & Fernández Pérez, E. R. (2024). Transcriptomic Profiling of Peripheral B Cells in Antibody Positive Sjogren’s Patients Reveals Interferon Signature. Genes. https://doi.org/10.3390/genes15050628
Vancouver
Maleki-Fischbach M, Anderson K, Fernández Pérez ER. Transcriptomic Profiling of Peripheral B Cells in Antibody Positive Sjogren’s Patients Reveals Interferon Signature. Genes. 2024. doi:10.3390/genes15050628
BibTeX
@article{MalekiFischbach2024,
author = {Maleki-Fischbach, Mehrnaz and Anderson, Kelsey and Fernández Pérez, Evans R},
title = {Transcriptomic Profiling of Peripheral B Cells in Antibody Positive Sjogren’s Patients Reveals Interferon Signature},
journal = {Genes},
year = {2024},
doi = {10.3390/genes15050628}
}
EUVIMED